The 20 Best Relapsed Refractory Multiple Myeloma (RRMM) Doctors Near Me in Oxford, MS
Find the Top Relapsed Refractory Multiple Myeloma (RRMM) Experts and Specialists
The 20 Best Relapsed Refractory Multiple Myeloma (RRMM) Doctors near Oxford, MS
MediFind found 5 doctor with experience in Relapsed Refractory Multiple Myeloma (RRMM) near Oxford, MS. Of these, 5 are Experienced.
Family Cancer Center PLLC
Ryan Yates is a Hematologist Oncology specialist and an Oncologist in Oxford, Mississippi. Dr. Yates is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Neuroendocrine Tumor, and Familial Colorectal Cancer.
Family Cancer Center PLLC
Clayton Allen is a Hematologist Oncology specialist and a Hematologist in Oxford, Mississippi. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Childhood Iron Deficiency Anemia, Angiosarcoma, Familial Colorectal Cancer, and Familial Pancreatic Cancer.
Family Cancer Center PLLC
Benton Wheeler is a Hematologist and an Oncologist in Oxford, Mississippi. Dr. Wheeler is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, and Non-Hodgkin Lymphoma.
John Cantrell is a Radiation Oncologist in Oxford, Mississippi. Dr. Cantrell is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Prostate Cancer, and Posterior Fossa Tumor.
Family Cancer Center PLLC
Tammy Pelegrin is a Nurse Practitioner in Oxford, Mississippi. Ms. Pelegrin is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Gastroesophageal Junction Cancer, Smoldering Multiple Myeloma, ALK-Positive Non-Small Cell Lung Cancer, and Marginal Zone Lymphoma (MZL).
Last Updated: 02/22/2026